USPTO serial 79257663
Serial No. 79257663
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 6, 2020
- Examiner
- NEPTUNE, EVONNE MARIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79257663?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Zhongshan, CN
Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Zhongshan, CN
Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Zhongshan, CN
Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Chinhwei Chen
Chinhwei Chen Jianq Chyun Intellectual Property Office7F.-1, No. 100, Roosevelt Rd. Sec. 2Taipei, 10084TAIWANGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicine for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; Chinese patent medicines being medicines for the treatment of gastrointestinal system, respiratory system, genitourinary system, endocrine system, nervous system, circulatory system and musculoskeletal system related diseases and for the treatment of colds and flu, skin diseases, tumors, dental and oral diseases; medicinal tea; disinfectants; dietetic foods adapted for medical purpose; depuratives for the body; medicines for veterinary purposes, namely, veterinary medicine for antimicrobial and anti-parasitic treatment, for promoting growth of animals and for the treatment of nervous, gastrointestinal, respiratory and metabolic system related diseases; food for babies; medicinal drinks; dietary fiber to reduce cholesterol, regulate lipids in blood, regulate immune functions, increase satiety feelings, prevent diabetes, balance intestinal flora, prevent intestinal and breast cancer, nourish skins, prevent and alleviate constipation; semen for artificial insemination; teeth filling material; diapers for pets; gases for medical purposes; chemical conductors for electrocardiograph electrodes; solutions for contact lenses; bouillons for bacteriological cultures; radioactive drugs for medical purposes; preparations for destroying noxious animals; tissues impregnated with pharmaceutical lotions for the purpose of moisturizing, antimicrobial treatment, anti-inflammatory treatment, pain relief and the treatment of skin disease; dressings, medical; medicinal herbs in fabric containers for incorporating into pillows for medical purposes; medicinal herbs | ACTIVE | — |
| 030 | Vegetal preparations for use as coffee substitutes; tea; tea-based beverages; honey; cereal-based snack food; flowers or leaves for use as tea substitutes; nut flours; cooking salt; vinegar; preparations for stiffening whipped cream, namely, starch-based thickeners; peppermint sweets; cereal preparations, namely, cereal-based snack food; seasonings; food additives for non-industrial use, namely, gluten additives for culinary purposes; meat tenderizers for household purposes; natural sweeteners; yeast; rice-based snack food; starch for food; ice cream; malt for food purposes; dried pieces of wheat gluten | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
- Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
- Other trademarks owned by Zhongshan Zhongzhi Pharmaceutical Group Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 030
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 7, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 23, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 23, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 6, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 6, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 31, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 15, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 15, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 9, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 9, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 9, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 26, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 26, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 26, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 7, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 7, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 7, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 19, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 23, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 22, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 18, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 18, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 17, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 17, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 10, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 8, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 7, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 6, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 2, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |